All Stories

  1. IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML

    Article • OncoImmunology, July 2018, Taylor & Francis

    Dr Eduardo Anguita, Dr. Jose L Fuster

  2. PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase

    Article • PLoS ONE, July 2017, PLOS

    Dr Eduardo Anguita

  3. Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes

    Article • Stem Cell Reports, June 2017, Elsevier

    Dr Eduardo Anguita, Josep Nomdedeu

  4. Amplification of mixed lineage leukemia gene perturbs hematopoiesis and cooperates with partial tandem duplication to induce acute myeloid leukemia

    Article • Haematologica, May 2017, Ferrata Storti Foundation (Haematologica)

    Dr Eduardo Anguita

  5. Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition

    Article • Oncotarget, May 2017, Impact Journals, LLC

    Dr Eduardo Anguita

  6. Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology

    Article • British Journal of Haematology, April 2017, Wiley

    Dr Eduardo Anguita

  7. Transcription Factor GFI1B in Health and Disease

    Article • Frontiers in Oncology, March 2017, Frontiers

    Dr Eduardo Anguita

  8. Splenectomy in ITP: we keep removing a healthy functional organ

    Article • Annals of Hematology, August 2016, Springer Science + Business Media

    Dr Eduardo Anguita

  9. A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network

    Article • Developmental Biology, March 2016, Elsevier

    Dr Eduardo Anguita

  10. A newNPM1gene mutation

    Article • Leukemia & Lymphoma, June 2015, Taylor & Francis

    Dr Eduardo Anguita

  11. Bone marrow mesenchymal stem cells from aplastic anemia patients preserve functional and immune properties and do not contribute to the pathogenesis of the disease

    Article • Experimental Hematology, August 2014, Elsevier

    Dr Eduardo Anguita

  12. Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease

    Article • Haematologica, April 2014, Ferrata Storti Foundation (Haematologica)

    Dr Eduardo Anguita

  13. Caracterización molecular de dos nuevas mutaciones de α° talasemia en 2 familias españolas (mutación --ED y --GP)

    Article • Medicina Clínica, May 2011, Elsevier

    Dr Eduardo Anguita

  14. Human promoter mutations unveil Oct-1 and GATA-1 opposite action on Gfi1b regulation

    Article • Annals of Hematology, February 2010, Springer Science + Business Media

    Dr Eduardo Anguita

  15. GFI1B controls its own expression binding to multiple sites

    Article • Haematologica, September 2009, Ferrata Storti Foundation (Haematologica)

    Dr Eduardo Anguita

  16. Haemoglobinopathies with high oxygen affinity. Experience of Erythropathology Cooperative Spanish Group

    Article • Annals of Hematology, September 2008, Springer Science + Business Media

    Dr Eduardo Anguita

  17. Tissue-specific histone modification and transcription factor binding in   globin gene expression

    Article • Blood, December 2007, American Society of Hematology

    Dr Eduardo Anguita

  18. How transcriptional and epigenetic programmes are played out on an individual mammalian gene cluster during lineage commitment and differentiation

    Article • Biochemical Society Symposia, January 2006, Portland Press Ltd.

    Dr Eduardo Anguita

  19. Understanding α-Globin Gene Regulation: Aiming to Improve the Management of Thalassemia

    Article • Annals of the New York Academy of Sciences, November 2005, Wiley

    Dr Eduardo Anguita

  20. Annotation of cis-regulatory elements by identification, subclassification, and functional assessment of multispecies conserved sequences

    Article • Proceedings of the National Academy of Sciences, July 2005, Proceedings of the National Academy of Sciences

    Dr Eduardo Anguita

  21. Differences in the chromatin structure and cis-element organization of the human and mouse GATA1 loci: implications for cis-element identification

    Article • Blood, November 2004, American Society of Hematology

    Dr Eduardo Anguita

  22. Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2

    Article • The EMBO Journal, June 2004, Wiley

    Dr Eduardo Anguita

  23. Deletion of the mouse alpha -globin regulatory element (HS -26) has an unexpectedly mild phenotype

    Article • Blood, July 2002, American Society of Hematology

    Dr Eduardo Anguita

  24. Identification of a conserved erythroid specific domain of histone acetylation across the α-globin gene cluster

    Article • Proceedings of the National Academy of Sciences, October 2001, Proceedings of the National Academy of Sciences

    Dr Eduardo Anguita

  25. Deletion of BCR region 3′ in chronic myelogenous leukemia

    Article • Cancer Genetics and Cytogenetics, October 2001, Elsevier

    Dr Eduardo Anguita

  26. Monosomy for the most telomeric, gene-rich region of the short arm of human chromosome 16 causes minimal phenotypic effects

    Article • European Journal of Human Genetics, March 2001, Nature

    Dr Eduardo Anguita

  27. THE THALASSEMIA SYNDROMES: MOLECULAR CHARACTERIZATION IN THE SPANISH POPULATION

    Article • Hemoglobin, January 2001, Taylor & Francis

    Dr Eduardo Anguita

  28. Association of t(9;11)-MLL AF9 and Trisomy 8 in an AML-M5 Preceded by Pancytopenia

    Article • Cancer Genetics and Cytogenetics, July 2000, Elsevier

    Dr Eduardo Anguita

  29. Acute promyelocytic leukemia relapse in the central nervous system during hematologic and molecular remission

    Article • American Journal of Hematology, February 1999, Wiley

    Dr Eduardo Anguita

  30. Late relapse in BCR/ABL-positive patients after non-intensive chemotherapy

    Article • Leukemia, June 1998, Nature

    Dr Eduardo Anguita

  31. The first report of a Philadelphia chromosome and BCR/ABL rearrangement positive myeloproliferative disorder in a child with thrombocythemia

    Article • Leukemia, March 1998, Nature

    Dr Eduardo Anguita

  32. Occurrence of BCR-ABL rearrangement in a Philadelphia chromosome-negative patient with 5q and 13q deletions and myeloproliferative syndrome

    Article • Cancer Genetics and Cytogenetics, January 1998, Elsevier

    Dr Eduardo Anguita

  33. Bcl-2 gene rearrangement: Diagnostic implications in a case of a large cell diffuse lymphoma appearing in leukemic phase

    Article • American Journal of Hematology, September 1995, Wiley

    Dr Eduardo Anguita